Amigen Biosciences
Strategy. Execution. Access.
Across the full value chain.
Creating value beyond molecules.
Amigen Biosciences is a boutique consulting and business development firm. We support pharmaceutical, biotech, medical device, and advanced healthcare companies to build, structure, and execute sustainable business models across emerging markets — combining strategy, regulatory know-how, partner networks, and hands-on execution across the full value chain.
Strong regulatory execution. Reliable supply chains. Trusted partners. Disciplined commercial leadership.
Global and regional healthcare companies face a common challenge: the markets with the greatest unmet need are also the most complex to enter. Regulatory pathways differ by country. Supply chains are fragmented. Commercial infrastructure is thin. The cost of getting it wrong is high.
Amigen was built to solve exactly this. We combine deep regulatory expertise, established partner networks, and hands-on commercial execution to help our clients build sustainable, compliant, and profitable operations across emerging markets.
We work across pharmaceuticals, biotech, medical devices, and advanced healthcare solutions — supporting business development, regulatory execution, licensing, trading, supply chain development, and market access from a single, accountable partner.
The result is not just market entry. It is a durable business model, built to last.
How It Works
The Model
We Structure
We work with clients to define the right market entry strategy — identifying the optimal licensing, partnership, or trading structure, and building the regulatory and commercial roadmap to execute it.
We Execute
Our regulatory and BD teams manage the full execution pathway — from dossier preparation and agency liaison to licensing negotiations, supply chain setup, and partner onboarding.
We Deliver
With approvals secured and infrastructure in place, we drive commercial launch and ongoing market access — building the presence that makes access real, not theoretical.
What We Do
Our Service Lines
Market Analysis & Commercial Strategy
Rigorous market intelligence and go-to-market strategy to identify the right opportunities and build a credible, executable plan across emerging markets.
Licensing, Partnerships & Commercial Structuring
End-to-end support for in-licensing and out-licensing — identifying partners, negotiating terms, and structuring commercially sound agreements across all product categories.
Regulatory Affairs, Compliance & Market Access
Full local registration management — dossier preparation, agency liaison, query response, and approval — combined with ongoing compliance and market access support.
Trading, Supply Chain & Operational Setup
Supply chain frameworks, trading structures, and operational infrastructure that make market entry viable — built with the rigour that healthcare demands.
Business Intelligence & Due Diligence
Thorough asset evaluation and due diligence to support licensing decisions, partnership structuring, and investment in complex, information-scarce markets.
Our Reach
Where We Work
Amigen operates across the emerging markets of the Middle East, Africa, and beyond — regions where the gap between proven medicine and patient access is widest, and where the opportunity to close it is most meaningful.
Middle East
Gulf Cooperation Council and broader MENA region
North Africa
Egypt, Morocco, Tunisia, and the Maghreb
Sub-Saharan Africa
Key markets across East and West Africa
Broader Emerging Markets
Selective expansion into high-need markets globally
Partner with Amigen
Creating value beyond molecules.
Whether you are an originator, a CDMO, or a CMO that has developed a unique product and is looking for a partner to license and launch it across emerging markets — we should talk. We handle everything from in-licensing to local regulatory approval and commercialisation.